Spatial Cell Control

Spatial Cell Control is a technology developed by BioCorp in the mid-22nd century that suspends cells in a forcefield at the molecular level and allows for an unprecedented level of precision in manipulation. Originally intended to treat incurable metastatic cancers, it effectively revolutionised the bioscience industry. The technology is underpinned by heuristic DNA editing, a foundational tool which allows engineers to rapidly make changes to target genomes. The first Spatial Cell Control systems were based on two technologies licensed from Metatron: Dynamic Containment Array forcefields and Interdiction Matrix particle beam systems.

Vignette

“Today, BioCorp announces the SC-100 series of Spatial Cell Control smart surgery machines, revolutionising the biomedical sector. The platform, based on the latest Dynamic Containment Array forcefield technology and particle-based three-dimensional matter manipulation systems, unlocks uncountable treatment possibilities, and makes tissue deep within the body just as accessible as surface layers. Excise tumours and lay in replacement tissue in a single command set; repair organs, the circulatory system, and more. The SC-100 doesn’t just cure cancer; it cures everything.”